Paladin Labs has launched Silenor (doxepin hydrochloride), specified for the treatment and symptomatic relief of insomnia with characteristics of frequent nocturnal awakening and/or early morning awakenings, in Canada. Silenor, which is ...
Asmacure has commenced phase 1/2 trial of ASM-024 dry powder for inhalation (DPI) formulation with multi-functional mechanism of action with nicotinic and muscarinic effects. In pre-clinical asthma models ASM-024 exhibited the ...
Tags: Asmacure, Dry Powder, Inhalation
US-based healthcare company electroCore has raised $40m from Merck's Global Healthcare Innovation Fund. Other participants in the round of financing are private equity groups including Easton Capital and Core Ventures. The company will ...
Tags: Electrocore, Therapy Device, Medicine
Aeterna Zentaris has signed a co-development and profit sharing agreement with Ergomed Clinical Research for AEZS-108 in endometrial cancer. Ergomed has been selected as the contract clinical development organization to conduct the Phase ...
The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
The US Food and Drug Administration (FDA) has approved Biogen Idec's Tecfidera (dimethyl fumarate), a new first-line oral capsule for people suffering from relapsing forms of multiple sclerosis (MS). Tecfidera reduces relapses and ...
Tags: FDA, Biogen capsule, multiple sclerosis
The US FDA has cleared Eisai's ACIPHEX Sprinkle (rabeprazole sodium) as 12-week gastroesophageal reflux disease (GERD) therapy for use in children between one to eleven years age. The approval was based on positive data from multicenter, ...
Tags: FDA, Disease Therapy for Children, Medicine
Pfizer and Protalix BioTherapeutics have obtained approval from the Brazilian National Health Surveillance Agency for Uplyso (alfataliglicerase) as type I Gaucher disease therapy. Uplyso, referred to as Elelyso (taliglucerase alfa) ...
Tags: Pfizer, Protalix, Protalix BioTherapeutics
Abbott has presented clinical study data from a Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II ) High Surgical Risk cohort of its MitraClip System for the treatment of mitral regurgitation (MR). The CE-marked catheter-based ...
Tags: clinical study, MitraClip System, medical
Takeda Pharmaceutical Company has submitted marketing authorisation application (MAA) seeking approval from the European Medicines Agency (EMA) for its investigational, gut-selective humanized monoclonal antibody for the treatment of adults ...
Tags: Takeda, IBD Disease Drug, MAA, EMA
Aesculap, a B Braun company, has launched an adjustable, gravitational shunt valve, Miethke proSA, to provide surgeons with a new treatment option for patients with hydrocephalus. The valve provides resistance to cerebral spinal fluid ...
Tags: Aesculap, treatment option, Hydrocephalus
Medtronic has obtained regulatory approval from the US Food and Drug Administration (FDA) to conduct an early feasibility study on its Native Outflow Tract transcatheter pulmonary valve (TPV), designed for the treatment of patients with ...
Tags: Medtronic, Native Outflow TPV, Medicine
Expanding Orthopedics, a spinal device company, Vin Germany for a clinical study of its XPED Expanding Pedicle Screw system. The system, which is commercially available in Europe, is designed to provide improved anchoring of the implant ...
Tags: Expanding Orthopedics, Clinical Study, Pedicle Screw System
Food and Drug Administration (FDA) has approved US-based pharmaceutical company Shionogi's Osphena (ospemifene) tablets for the treatment of moderate to severe dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy ...
Tags: FDA, Dyspareunia, Medicine
Therapeutic Goods Administration in Australia and the National Institute of Surveillance of Medicine and Foods in the Ministry of Health in Colombia have approved ElectroCore's non-invasive, non-pharmaceutical vagus nerve stimulation ...
Tags: ElectroCore, Therapeutic Goods, Medicine